Nantahala Capital Management, LLC: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1472322) · Explore on the interactive board
Nantahala Capital Management, LLC disclosed 132 US equity positions worth $1.7bn in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 19, 2026). Its largest position is TBBK at 4.7% of the reported book, followed by BVS, HGV. The top ten holdings are 27.4% of the book, and the portfolio behaves like about 65 equal-weight positions. Versus the prior filing it opened 22 new positions, added to 24, reduced 39 and exited 20. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Nantahala Capital Management, LLC own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 22 new, 24 added, 39 reduced, 20 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | TBBK BANCORP INC DEL | Financial Services | 4.7% | $77.7m | 1,239,887 | -10% | reduced |
| 2 | BVS BIOVENTUS INC | Healthcare | 3.4% | $56.6m | 6,000,279 | -2% | reduced |
| 3 | HGV HILTON GRAND VACATIONS INC | Consumer Cyclical | 3.3% | $54.1m | 1,033,170 | -32% | reduced |
| 4 | SVRA SAVARA INC | Healthcare | 2.6% | $43.0m | 6,976,810 | -5% | reduced |
| 5 | ETON ETON PHARMACEUTICALS INC | 2.6% | $42.6m | 1,175,951 | 0% | held | |
| 6 | AMRX AMNEAL PHARMACEUTICALS INC | Healthcare | 2.4% | $39.3m | 2,268,751 | -20% | reduced |
| 7 | EOLS EVOLUS INC | Healthcare | 2.3% | $38.9m | 5,602,021 | -12% | reduced |
| 8 | AVTX AVALO THERAPEUTICS INC | Healthcare | 2.1% | $34.4m | 1,862,250 | 51% | added |
| 9 | LB PHARMACEUTICALS INC | 2.1% | $34.2m | 1,052,894 | 0% | held | |
| 10 | AVR ANTERIS TECHNOLOGIES GLOBAL | 2.0% | $33.3m | 3,383,335 | -39% | reduced | |
| 11 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 1.9% | $31.7m | 5,136,490 | 2% | added |
| 12 | PTON PELOTON INTERACTIVE INC | Consumer Cyclical | 1.8% | $30.2m | 5,108,995 | -57% | reduced |
| 13 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 1.7% | $28.8m | 335,830 | -60% | reduced |
| 14 | XTNT XTANT MED HLDGS INC | 1.7% | $28.8m | 68,394,000 | 0% | held | |
| 15 | JACK JACK IN THE BOX INC | Consumer Cyclical | 1.7% | $27.3m | 1,728,659 | 12% | added |
| 16 | GOGO GOGO INC | Communication Services | 1.6% | $27.0m | 8,697,731 | -2% | reduced |
| 17 | IMAX IMAX CORP | Communication Services | 1.6% | $26.2m | 658,009 | 28% | added |
| 18 | ZVRA ZEVRA THERAPEUTICS INC | 1.6% | $25.8m | 1,797,476 | -29% | reduced | |
| 19 | TITN TITAN MACHY INC | Industrials | 1.4% | $23.9m | 1,133,088 | -10% | reduced |
| 20 | RMR RMR GROUP INC | 1.4% | $23.6m | 1,147,902 | 0% | held | |
| 21 | FOSL FOSSIL GROUP INC | Consumer Cyclical | 1.4% | $22.8m | 5,505,128 | 2% | added |
| 22 | FOXF FOX FACTORY HLDG CORP | Consumer Cyclical | 1.3% | $22.2m | 1,310,695 | -12% | reduced |
| 23 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.3% | $22.1m | 820,481 | -8% | reduced |
| 24 | RDNW RIDENOW GROUP INC | 1.3% | $21.8m | 3,272,845 | 0% | held | |
| 25 | UNIQURE NV | 1.3% | $21.0m | 455,660 | 92% | added | |
| 26 | AURA AURA BIOSCIENCES INC | 1.3% | $21.0m | 2,951,030 | 39% | added | |
| 27 | AGOMAB THERAPEUTICS NV | 1.2% | $20.4m | 1,568,188 | 31% | added | |
| 28 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.2% | $20.0m | 5,475,040 | 80% | added |
| 29 | BENITEC BIOPHARMA INC | 1.2% | $19.9m | 1,488,371 | 3% | added | |
| 30 | ADMA ADMA BIOLOGICS INC | Healthcare | 1.2% | $19.8m | 2,359,993 | – | new |
| 31 | CWH CAMPING WORLD HLDGS INC | Consumer Cyclical | 1.2% | $19.5m | 2,551,055 | -22% | reduced |
| 32 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.1% | $19.0m | 1,901,160 | -4% | reduced |
| 33 | MDXG MIMEDX GROUP INC | Healthcare | 1.1% | $18.4m | 4,767,552 | 40% | added |
| 34 | ABVX ABIVAX SA | Healthcare | 1.1% | $17.8m | 133,759 | -3% | reduced |
| 35 | USNA USANA HEALTH SCIENCES INC | Consumer Defensive | 1.0% | $17.3m | 810,074 | 0% | held |
| 36 | GLUE MONTE ROSA THERAPEUTICS INC | Healthcare | 1.0% | $15.8m | 651,993 | 0% | held |
| 37 | TNGX TANGO THERAPEUTICS INC | Healthcare | 0.9% | $15.7m | 500,659 | -60% | reduced |
| 38 | GERN GERON CORP | Healthcare | 0.9% | $15.6m | 12,225,000 | 9% | added |
| 39 | VOR VOR BIOPHARMA INC | Healthcare | 0.9% | $15.6m | 845,000 | – | new |
| 40 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.9% | $15.1m | 1,410,419 | 4% | added |
| 41 | SLN SILENCE THERAPEUTICS PLC | 0.9% | $14.8m | 1,346,731 | -37% | reduced | |
| 42 | APYX APYX MEDICAL CORPORATION | Healthcare | 0.9% | $14.7m | 3,270,248 | -5% | reduced |
| 43 | JCAP JEFFERSON CAPITAL INC | 0.9% | $14.6m | 750,000 | 0% | held | |
| 44 | HLF HERBALIFE LTD | Consumer Defensive | 0.9% | $14.6m | 1,109,154 | -18% | reduced |
| 45 | PLNT PLANET FITNESS MASTER ISSUER | Consumer Cyclical | 0.9% | $14.6m | 279,000 | – | new |
| 46 | VSTM VERASTEM INC | Healthcare | 0.8% | $13.7m | 3,584,820 | 0% | held |
| 47 | DSGR DISTRIBUTION SOLUTIONS GRP I | 0.8% | $13.5m | 494,581 | 0% | held | |
| 48 | RYAM RAYONIER ADVANCED MATLS INC | Basic Materials | 0.8% | $13.3m | 1,697,726 | 6% | added |
| 49 | HELIX ACQUISITION CORP III | 0.8% | $13.3m | 1,250,000 | 0% | held | |
| 50 | ADCT ADC THERAPEUTICS SA | Healthcare | 0.8% | $13.2m | 12,326,184 | 120% | added |
What did Nantahala Capital Management, LLC sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| SLNOEUR SOLENO THERAPEUTICS INC | 40.4% | $58.4m |
| AH30 ASSERTIO HOLDINGS INC | 9.1% | $13.2m |
| CNTA CENTESSA PHARMACEUTICALS PLC | 7.0% | $10.1m |
| COGT COGENT BIOSCIENCES INC | 6.7% | $9.6m |
| SLDB SOLID BIOSCIENCES INC | 5.8% | $8.4m |
| DNTH DIANTHUS THERAPEUTICS INC | 3.9% | $5.6m |
| KOS KOSMOS ENERGY LTD | 3.5% | $5.1m |
| RVMD REVOLUTION MEDICINES INC | 3.4% | $4.9m |
| CZR CAESARS ENTERTAINMENT INC NE | 2.7% | $4.0m |
| UPB UPSTREAM BIO INC | 2.5% | $3.6m |
| NNBR NN INC | 2.4% | $3.5m |
| GRCE GRACE THERAPEUTICS INC | 2.3% | $3.4m |
| CGON CG ONCOLOGY INC | 2.3% | $3.3m |
| XNCR XENCOR INC | 2.2% | $3.2m |
| IMUX IMMUNIC INC | 1.9% | $2.8m |
| ACHV ACHIEVE LIFE SCIENCE INC | 1.3% | $1.9m |
| IRON DISC MEDICINE INC | 1.1% | $1.6m |
| PEPG PEPGEN INC | 0.8% | $1.2m |
| SNTI SENTI BIOSCIENCES INC | 0.5% | $721.1k |
| PERFECT CORP | 0.0% | $238 |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 38.3% |
| Consumer Cyclical | 12.7% |
| Financial Services | 5.2% |
| Communication Services | 3.3% |
| Consumer Defensive | 2.3% |
| Industrials | 1.8% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Nantahala Capital Management, LLC's portfolio?
Across every quarter Nantahala Capital Management, LLC has filed, its median largest position is 4.7% of the book and its median top-ten weight is 29.2%, which WhaleCreep classifies as diversified (the gate is a median largest position of 5%). Of 19.0 completed holding spells, the median lasted 1.0 quarters; 132.0 positions are still open and their final length is unknown.